HIMS:NYE-Hims Hers Health Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 16.17

Change

-1.39 (-7.92)%

Market Cap

USD 2.64B

Volume

0.02B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
PG Procter & Gamble Company

N/A

USD 397.61B
UL Unilever PLC ADR

N/A

USD 138.25B
CL Colgate-Palmolive Company

N/A

USD 77.09B
KMB Kimberly-Clark Corporation

N/A

USD 45.42B
EL Estee Lauder Companies Inc

N/A

USD 42.17B
CHD Church & Dwight Company Inc

N/A

USD 26.24B
CLX The Clorox Company

N/A

USD 16.60B
ELF ELF Beauty Inc

N/A

USD 10.32B
COTY Coty Inc

N/A

USD 8.85B
SPB Spectrum Brands Holdings Inc

N/A

USD 2.59B

ETFs Containing HIMS

EDOC:LSE Global X Telemedicine & D.. 5.04 % 0.00 %

N/A

USD 4.72M
EDOG:LSE Global X Telemedicine & D.. 4.87 % 0.00 %

N/A

USD 0.15M
DDOC:XETRA Global X Telemedicine & D.. 4.10 % 0.00 %

N/A

USD 5.39M
DDOC:F Global X Telemedicine & D.. 4.10 % 0.00 %

N/A

USD 4.76M
EDOC:SW Global X Telemedicine & D.. 4.10 % 0.00 %

N/A

USD 4.69M
FDOC:LSE Fidelity Digital Health U.. 3.94 % 0.00 %

N/A

USD 2.85M
IBUY Amplify Online Retail ETF 3.89 % 0.65 %

N/A

USD 0.18B
FDHT:XETRA Fidelity Digital Health U.. 3.00 % 0.00 %

N/A

USD 2.87M
WELP:LSE HAN-GINS Indxx Healthcare.. 2.97 % 0.00 %

N/A

USD 0.02B
W311:F HAN-GINS Indxx Healthcare.. 2.40 % 0.00 %

N/A

USD 0.02B
WELL:PA HAN-GINS Indxx Healthcare.. 2.40 % 0.00 %

N/A

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 2.40 % 0.00 %

N/A

N/A
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

N/A

USD 0.09B
FYC First Trust Small Cap Gro.. 0.00 % 0.70 %

N/A

USD 0.27B
FYX First Trust Small Cap Cor.. 0.00 % 0.63 %

N/A

USD 0.85B
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

N/A

USD 0.08B
WELL:LSE Hanetf Icav - Han-Gins He.. 0.00 % 0.00 %

N/A

USD 0.02B
W311:XETRA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 81.69% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 81.69% 100% F 99% N/A
Trailing 12 Months  
Capital Gain 83.54% 100% F 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.54% 100% F 96% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.09% 76% C+ 72% C
Dividend Return 11.09% 71% C- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 54.59% 18% F 16% F
Risk Adjusted Return 20.31% 41% F 42% F
Market Capitalization 2.64B 41% F 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.